Country
Germany
The German vaccine producer CureVac NV has completed a follow-on share issue on Nasdaq giving total gross proceeds of $517.5 million, including the exercise of the underwriters’ option.
Full text available to subscribers only. Click here for information on subscribing to MedNous.